Vetirus Pharmaceuticals Partners with Immune Propulsion to Develop IPVM-173
By adapting this unique IgG-degrading technology, we can offer pets with large tumors a targeted treatment that works with the body’s natural defenses. Full Press Release
VETIRUS IN THE NEWS
Accord Animal Health launches Vivinicord Chews® for dogs
Triple-action dental product designed to enhance oral health
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
